{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:18:53Z","timestamp":1790083133525,"version":"4.0.1"},"reference-count":78,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,17]]},"DOI":"10.18632\/oncotarget.13972","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T14:19:58Z","timestamp":1482157198000},"page":"4730-4746","source":"Crossref","is-referenced-by-count":64,"title":["Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model"],"prefix":"10.18632","volume":"8","author":[{"given":"Eonju","family":"Oh","sequence":"first","affiliation":[{"name":"Department of Bioengineering, College of Engineering, Hanyang University, Seongdong-gu, Seoul 133-791, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Kyu","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinWoo","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, College of Engineering, Hanyang University, Seongdong-gu, Seoul 133-791, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, College of Engineering, Hanyang University, Seongdong-gu, Seoul 133-791, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,10]]},"reference":[{"key":"1","first-page":"687","article-title":"Immune based therapies in cancer","volume":"22","author":"Korangy","year":"2007","journal-title":"Histol Histopathol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1523-1747.2000.00156.x","article-title":"Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration","volume":"115","author":"Ichihashi","year":"2000","journal-title":"J Invest Dermatol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00262-007-0343-y","article-title":"Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment","volume":"56","author":"Scharovsky","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"4","first-page":"295","article-title":"Genetically modified tumour vaccines carrying inserted genes for immunoregulatory molecules","volume":"42","author":"Bubenik","year":"1996","journal-title":"Folia Biol (Praha)"},{"key":"5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01517213","article-title":"Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?","volume":"41","author":"Rodolfo","year":"1995","journal-title":"Cancer Immunol Immunother"},{"key":"6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0952-7915(93)90127-E","article-title":"New strategies for enhancing the immunogenicity of tumors","volume":"5","author":"Pardoll","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"7","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","article-title":"Interleukin-12: biological properties and clinical application","volume":"13","author":"Anichini","year":"2007","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jgm.1356","article-title":"Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally","volume":"11","author":"Anwer","year":"2009","journal-title":"J Gene Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2741\/s306","article-title":"The regulation and activity of interleukin-12","volume":"4","author":"Waller","year":"2012","journal-title":"Front Biosci (Schol Ed)"},{"key":"10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(01)00032-6","article-title":"Interleukin-12 in anti-tumor immunity and immunotherapy","volume":"13","author":"Trinchieri","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14712598.2.5.513","article-title":"IL-12\/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside","volume":"2","author":"Wiltrout","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"12","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.1073\/pnas.0909474106","article-title":"Successful immunotherapy with IL-2\/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment","volume":"106","author":"Wiltrout","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Sotomayor","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/138161210790170175","article-title":"Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells","volume":"16","author":"Rabinovich","year":"2010","journal-title":"Curr Pharm Des"},{"key":"15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molonc.2011.03.007","article-title":"Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12","volume":"5","author":"Mazzolini","year":"2011","journal-title":"Mol Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Yun","year":"2011","journal-title":"Mol Ther"},{"key":"17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/mt.2009.205","article-title":"Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL","volume":"18","author":"Yun","year":"2010","journal-title":"Mol Ther"},{"key":"18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/gt.2011.125","article-title":"Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF","volume":"19","author":"Yun","year":"2012","journal-title":"Gene Ther"},{"key":"19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/gt.2011.37","article-title":"Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rbeta2 or IL-18Ralpha","volume":"18","author":"Yun","year":"2011","journal-title":"Gene Ther"},{"key":"20","doi-asserted-by":"crossref","first-page":"e67512","DOI":"10.1371\/journal.pone.0067512","article-title":"Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-gamma- and TNF-alpha-co-producing T cell-mediated antitumor immunity","volume":"8","author":"Yun","year":"2013","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bcp.2006.03.004","article-title":"TGF-beta in cancer and as a therapeutic target","volume":"72","author":"Teicher","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI31202","article-title":"Tregs and rethinking cancer immunotherapy","volume":"117","author":"Curiel","year":"2007","journal-title":"J Clin Invest"},{"key":"24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/sonc.2002.33076","article-title":"Immunologic mechanisms of antitumor activity","volume":"29","author":"Foss","year":"2002","journal-title":"Semin Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/cgt.2010.8","article-title":"Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation","volume":"17","author":"O'Sullivan","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/gt.2009.142","article-title":"Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy","volume":"17","author":"Yun","year":"2010","journal-title":"Gene Ther"},{"key":"27","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.4049\/jimmunol.0902736","article-title":"TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection","volume":"183","author":"Bishop","year":"2009","journal-title":"J Immunol"},{"key":"28","first-page":"1533","article-title":"Decorin suppresses lung metastases of murine osteosarcoma","volume":"19","author":"Uchida","year":"2008","journal-title":"Oncol Rep"},{"key":"29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)63447-5","article-title":"Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty","volume":"163","author":"Strauss","year":"2003","journal-title":"Am J Pathol"},{"key":"30","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/ijc.23930","article-title":"Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs","volume":"123","author":"Iozzo","year":"2008","journal-title":"Int J Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.cgt.7700176","article-title":"Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism","volume":"7","author":"Yang","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1158\/1535-7163.969.3.8","article-title":"Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody","volume":"3","author":"Sondel","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"33","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V93.5.1448","article-title":"Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling","volume":"93","author":"Chouaib","year":"1999","journal-title":"Blood"},{"key":"34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.166.4.991","article-title":"Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha","volume":"166","author":"Palladino","year":"1987","journal-title":"J Exp Med"},{"key":"35","first-page":"2939","article-title":"Pillars Article: production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth","volume":"192","author":"Fauci","year":"1986","journal-title":"J Exp Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.144.5.1767","article-title":"Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression","volume":"144","author":"Abraham","year":"1990","journal-title":"J Immunol"},{"key":"37","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4049\/jimmunol.147.8.2717","article-title":"A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus","volume":"147","author":"Biron","year":"1991","journal-title":"J Immunol"},{"key":"38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/exd.12719","article-title":"Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids","volume":"24","author":"Yun","year":"2015","journal-title":"Exp Dermatol"},{"key":"39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1567-5769(02)00251-5","article-title":"Potential involvement of monocyte chemoattractant protein (MCP)-1\/CCL2 in IL-4-mediated tumor immunity through inducing dendritic cell migration into the draining lymph nodes","volume":"3","author":"Mukaida","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/eji.200526208","article-title":"Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4","volume":"36","author":"Herlyn","year":"2006","journal-title":"Eur J Immunol"},{"key":"41","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1158\/0008-5472.CAN-12-2027","article-title":"Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response","volume":"72","author":"Mami-Chouaib","year":"2012","journal-title":"Cancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1582-4934.2011.01437.x","article-title":"Regulatory T cell: a protection for tumour cells","volume":"16","author":"Shen","year":"2012","journal-title":"J Cell Mol Med"},{"key":"43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semcancer.2012.03.004","article-title":"What are regulatory T cells (Treg) regulating in cancer and why?","volume":"22","author":"Whiteside","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"44","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","article-title":"Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection","volume":"25","author":"Tang","year":"2007","journal-title":"J Clin Oncol"},{"key":"45","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Wang","year":"2007","journal-title":"Gastroenterology"},{"key":"46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00262-009-0781-9","article-title":"Intratumoral CD8(+) T\/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer","volume":"59","author":"Katano","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cytogfr.2007.01.014","article-title":"Cytokine gene transfer for cancer therapy","volume":"18","author":"Mazzolini","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12185-011-0799-6","article-title":"The mechanisms of cancer immunoescape and development of overcoming strategies","volume":"93","author":"Kawakami","year":"2011","journal-title":"Int J Hematol"},{"key":"51","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1517\/14712598.7.11.1705","article-title":"Immunotherapy of cancer by IL-12-based cytokine combinations","volume":"7","author":"Wiltrout","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"52","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.181.3.901","article-title":"Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids","volume":"181","author":"Biron","year":"1995","journal-title":"J Exp Med"},{"key":"53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1749-6632.1996.tb52677.x","article-title":"Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials","volume":"795","author":"Tahara","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"54","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1126\/science.270.5238.908a","article-title":"IL-12 deaths: explanation and a puzzle","volume":"270","author":"Cohen","year":"1995","journal-title":"Science"},{"key":"55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Becher","year":"2015","journal-title":"Cell Death Differ"},{"key":"56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.virusres.2010.07.027","article-title":"Alphavirus vectors for cancer therapy","volume":"153","author":"Smerdou","year":"2010","journal-title":"Virus Res"},{"key":"57","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.4049\/jimmunol.154.12.6466","article-title":"Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector","volume":"154","author":"Lotze","year":"1995","journal-title":"J Immunol"},{"key":"58","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.4049\/jimmunol.1201791","article-title":"Eradication of liver-implanted tumors by Semliki Forest virus expressing IL-12 requires efficient long-term immune responses","volume":"190","author":"Smerdou","year":"2013","journal-title":"J Immunol"},{"key":"59","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/mthe.2002.0601","article-title":"IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma","volume":"5","author":"Heller","year":"2002","journal-title":"Mol Ther"},{"key":"60","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.gt.3300891","article-title":"Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity","volume":"6","author":"Pericle","year":"1999","journal-title":"Gene Ther"},{"key":"61","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s001090000165","article-title":"Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses","volume":"78","author":"Moelling","year":"2001","journal-title":"J Mol Med (Berl)"},{"key":"62","doi-asserted-by":"crossref","first-page":"11302","DOI":"10.1073\/pnas.93.21.11302","article-title":"Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma","volume":"93","author":"Chen","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"63","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.gt.3300834","article-title":"Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model","volume":"6","author":"Thompson","year":"1999","journal-title":"Gene Ther"},{"key":"64","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Licona-Limon","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2012.08.004","article-title":"More than matrix: the multifaceted role of decorin in cancer","volume":"92","author":"Viola","year":"2013","journal-title":"Eur J Cell Biol"},{"key":"66","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/bj3020527","article-title":"Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta","volume":"302","author":"Ruoslahti","year":"1994","journal-title":"Biochem J"},{"key":"67","doi-asserted-by":"crossref","first-page":"34712","DOI":"10.1074\/jbc.M111.262766","article-title":"Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling","volume":"286","author":"Morrione","year":"2011","journal-title":"J Biol Chem"},{"key":"68","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jconrel.2015.10.015","article-title":"Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model","volume":"220","author":"Yun","year":"2015","journal-title":"J Control Release"},{"key":"69","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.4049\/jimmunol.159.5.2125","article-title":"A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma","volume":"159","author":"Fujiwara","year":"1997","journal-title":"J Immunol"},{"key":"70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.20050463","article-title":"Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation","volume":"202","author":"Zitvogel","year":"2005","journal-title":"J Exp Med"},{"key":"71","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Wahl","year":"2003","journal-title":"J Exp Med"},{"key":"72","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","article-title":"Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7","volume":"172","author":"Neurath","year":"2004","journal-title":"J Immunol"},{"key":"73","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1073\/pnas.0501701102","article-title":"Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter","volume":"102","author":"Flavell","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"74","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1349-7006.2008.00951.x","article-title":"Optimal amount of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy against hepatocellular carcinoma by M1 macrophage activation","volume":"99","author":"Kaneko","year":"2008","journal-title":"Cancer Sci"},{"key":"75","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.4049\/jimmunol.173.3.1721","article-title":"MUC1\/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2","volume":"173","author":"Lopez","year":"2004","journal-title":"J Immunol"},{"key":"76","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1158\/1078-0432.CCR-06-0935","article-title":"Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model","volume":"12","author":"Yun","year":"2006","journal-title":"Clin Cancer Res"},{"key":"77","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/hum.2006.167","article-title":"E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects","volume":"18","author":"Yun","year":"2007","journal-title":"Hum Gene Ther"},{"key":"78","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2011.12.008","article-title":"Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers","volume":"158","author":"Kim","year":"2012","journal-title":"J Control Release"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:31:18Z","timestamp":1692613878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,10]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,1,17]]}},"alternative-id":["13972","28002796"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13972","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,10]]}}}